Directorate Change
Solarvalue AG
n/a
09:55 25/06/24
![](https://tracker.live.rns-distribution.com/track.live-rns/5229990_d9353a075fe0b610698e373da828b7e4.png)
Spectris plc (SXS: LSE) ("Spectris" or the "Company"), the expert in providing insight through precision measurement, today announces changes to its Board of Directors and Executive Committee.
Derek Harding to be appointed as President, Spectris Scientific and Angela Noon to join as Chief Financial Officer
Derek Harding to be appointed President, Spectris Scientific
Following the completion of our portfolio rationalisation, Derek Harding, will be taking up a new role as President of our enlarged Spectris Scientific Division, which encompasses our Malvern Panalytical, PMS and Servomex businesses. Derek has served as an Executive Director and Chief Financial Officer of Spectris since March 2019 and will continue in his role as Chief Financial Officer until 1 September 2024 when he will start his new position. Derek will remain on the Board as an Executive Director of the Company in his new role and will continue to report to Andrew Heath, Chief Executive.
Mark Fleiner, the current President of Spectris Scientific, will leave the Group later in 2024 following five years with the Group during which he has overseen a compound annual growth rate of 6.5%.
Angela Noon to join Spectris as Chief Financial Officer
Angela Noon will join the Company as an Executive Director and Chief Financial Officer on 1 September 2024. Angela is currently CFO at Royal Mail and was previously CFO for Siemens UK & Ireland. Angela, a chartered management accountant, will bring more than 25 years of finance and commercial experience to the role, as well as considerable and highly relevant industrial end-market experience. She is also currently a member of the Supervisory Board of Just Eat Takeaway N.V. and Chair of their Audit Committee. Prior to joining the Royal Mail, Angela spent over 20 years in various international leadership roles at Siemens AG in digitalisation, industrial software and business development.
Commenting on the appointments, Andrew Heath, Chief Executive of Spectris said, "The Spectris Scientific Division combines three great businesses with an exciting future, and I am looking forward to working closely with Derek in his new capacity to continue to deliver on our strategic growth ambitions. We are uniquely positioned in high-end growth markets, with a strong and innovative portfolio of products and services developed and driven by a talented and dedicated workforce. I am hugely grateful to Mark Fleiner for his instrumental role in the creation and growth of the Division over the past five years and I wish him the very best for the future. I am delighted that Angela is joining Spectris as our new CFO. She will be a great addition to the team, bringing significant financial and commercial experience from the industrial and technology sectors."
Mark Williamson, Chairman of Spectris said, "The strong appointments we are announcing today will further support the delivery of our Strategy for Sustainable Growth over the coming years. Derek is a valued colleague on the Board, and I look forward to the energy and focus he will bring to the leadership of the Spectris Scientific Division. Angela will be a very strong addition to the Board and Executive Team, and I am looking forward to welcoming her to Spectris in September."
There are no further details to be disclosed in respect of Listing Rule 9.6.13.
END
For and on behalf of Spectris plc
LEI Number: 213800Z4CO2CZO3M3T10
Contacts:
Spectris plc
Mathew Wootton
Investor Relations Director
+44 (0)7500 078880
Teneo
Martin Robinson/Giles Kernick
+44 20 7353 4200
About Spectris
Spectris combines precision with purpose, delivering progress for a more sustainable world. We provide critical insights to our customers through premium precision measurement solutions combined with technical expertise and deep domain knowledge. Precision is at the heart of what we do - our leading, high-tech instruments and software equip our customers to solve some of their greatest challenges to make the world cleaner, healthier and more productive. We are focused on two key divisions - Spectris Scientific and Spectris Dynamics, which are placed in technology-driven end markets, with strong fundamentals and attractive growth trajectories. We have leading market positions in premium segments and employ 7,600 people located in more than 30 countries, all united behind our purpose to deliver value beyond measure for all our stakeholders. For more information, visit www.spectris.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.